Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 566

1.

A Risk Assessment of Factors for the Presence of Angiodysplasias During Endoscopy and Factors Contributing to Symptomatic Bleeding and Rebleeds.

Grooteman KV, Holleran G, Matheeuwsen M, van Geenen EJM, McNamara D, Drenth JPH.

Dig Dis Sci. 2019 Jun 12. doi: 10.1007/s10620-019-05683-7. [Epub ahead of print] Review.

PMID:
31190204
2.

Long-term risk of advanced neoplasia after colonic low-grade dysplasia in patients with inflammatory bowel disease: a nationwide cohort study.

de Jong ME, van Tilburg SB, Nissen LHC, Kievit W, Nagtegaal ID, Horjus CS, Römkens TEH, Drenth JPH, Hoentjen F, Derikx LAAP.

J Crohns Colitis. 2019 Jun 7. pii: jjz114. doi: 10.1093/ecco-jcc/jjz114. [Epub ahead of print]

PMID:
31175827
3.

A Novel Automatic Digital Algorithm that Accurately Quantifies Steatosis in NAFLD on Histopathological Whole-Slide Images.

Munsterman ID, van Erp M, Weijers G, Bronkhorst C, de Korte CL, Drenth JPH, van der Laak JAWM, Tjwa ETTL.

Cytometry B Clin Cytom. 2019 Jun 7. doi: 10.1002/cyto.b.21790. [Epub ahead of print]

PMID:
31173462
4.

Surveillance endoscopy after ureterosigmoidostomy.

Kramer M, Siersema PD, Drenth JPH.

Endoscopy. 2019 Jun 4. doi: 10.1055/a-0885-9381. [Epub ahead of print] No abstract available.

PMID:
31163488
5.

Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia.

Huppke P, Wegener E, Gilley J, Angeletti C, Kurth I, Drenth JPH, Stadelmann C, Barrantes-Freer A, Brück W, Thiele H, Nürnberg P, Gärtner J, Orsomando G, Coleman MP.

Exp Neurol. 2019 May 24;320:112958. doi: 10.1016/j.expneurol.2019.112958. [Epub ahead of print]

PMID:
31132363
6.

Etiologies of Long-Term Postcholecystectomy Symptoms: A Systematic Review.

Latenstein CSS, Wennmacker SZ, de Jong JJ, van Laarhoven CJHM, Drenth JPH, de Reuver PR.

Gastroenterol Res Pract. 2019 Apr 14;2019:4278373. doi: 10.1155/2019/4278373. eCollection 2019. Review.

7.

The revised Atlanta criteria more accurately reflect severity of post-ERCP pancreatitis compared to the consensus criteria.

Smeets X, Bouhouch N, Buxbaum J, Zhang H, Cho J, Verdonk RC, Römkens T, Venneman NG, Kats I, Vrolijk JM, Hemmink G, Otten A, Tan A, Elmunzer BJ, Cotton PB, Drenth J, van Geenen E.

United European Gastroenterol J. 2019 May;7(4):557-564. doi: 10.1177/2050640619834839. Epub 2019 Feb 27.

8.

How to best measure quality of life in coeliac disease? A validation and comparison of disease-specific and generic quality of life measures.

Burger JPW, van Middendorp H, Drenth JPH, Wahab PJ, Evers AWM.

Eur J Gastroenterol Hepatol. 2019 Apr 30. doi: 10.1097/MEG.0000000000001432. [Epub ahead of print]

PMID:
31045631
9.

Restrictive strategy versus usual care for cholecystectomy in patients with gallstones and abdominal pain (SECURE): a multicentre, randomised, parallel-arm, non-inferiority trial.

van Dijk AH, Wennmacker SZ, de Reuver PR, Latenstein CSS, Buyne O, Donkervoort SC, Eijsbouts QAJ, Heisterkamp J, Hof KI', Janssen J, Nieuwenhuijs VB, Schaap HM, Steenvoorde P, Stockmann HBAC, Boerma D, Westert GP, Drenth JPH, Dijkgraaf MGW, Boermeester MA, van Laarhoven CJHM.

Lancet. 2019 Jun 8;393(10188):2322-2330. doi: 10.1016/S0140-6736(19)30941-9. Epub 2019 Apr 27. Erratum in: Lancet. 2019 May 11;393(10184):1936.

PMID:
31036336
10.

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.

van Aerts RMM, Kievit W, D'Agnolo HMA, Blijdorp CJ, Casteleijn NF, Dekker SEI, de Fijter JW, van Gastel M, Gevers TJ, van de Laarschot LFM, Lantinga MA, Losekoot M, Meijer E, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Visser FW, Wetzels JF, Zietse R, Gansevoort RT, Drenth JPH; DIPAK-1 Investigators.

Gastroenterology. 2019 Apr 22. pii: S0016-5085(19)36711-3. doi: 10.1053/j.gastro.2019.04.018. [Epub ahead of print]

PMID:
31022403
11.

Venous Stent Placement for Refractory Ascites due to Hepatic Venous Outflow Obstruction in Polycystic Liver Disease: A Case Report.

Bernts LHP, Tjwa ETTL, D'Agnolo HMA, Jenniskens SFM, Drenth JPH.

J Vasc Interv Radiol. 2019 Apr 17. pii: S1051-0443(18)31496-9. doi: 10.1016/j.jvir.2018.09.011. [Epub ahead of print] No abstract available.

PMID:
31005489
12.

Carbamazepine intervention in a patient with efavirenz-induced liver injury.

Jacobs TG, Burger DM, Pranger AD, Khoo SH, Drenth JPH, van Crevel R.

AIDS. 2019 May 1;33(6):1097-1098. doi: 10.1097/QAD.0000000000002116. No abstract available.

PMID:
30946165
13.

Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study.

Trauner M, Nevens F, Shiffman ML, Drenth JPH, Bowlus CL, Vargas V, Andreone P, Hirschfield GM, Pencek R, Malecha ES, MacConell L, Shapiro D.

Lancet Gastroenterol Hepatol. 2019 Jun;4(6):445-453. doi: 10.1016/S2468-1253(19)30094-9. Epub 2019 Mar 26.

PMID:
30922873
14.

Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation.

Betzel B, Cooiman MI, Aarts EO, Janssen IMC, Wahab PJ, Groenen MJM, Drenth JPH, Berends FJ.

Surg Endosc. 2019 Mar 14. doi: 10.1007/s00464-019-06752-8. [Epub ahead of print]

PMID:
30877567
15.

United European Gastroenterology Journal making the next step.

Drenth JP.

United European Gastroenterol J. 2019 Feb;7(1):5-6. doi: 10.1177/2050640618822884. Epub 2019 Jan 30. No abstract available.

16.

Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop.

Dyson JK, De Martin E, Dalekos GN, Drenth JPH, Herkel J, Hubscher SG, Kelly D, Lenzi M, Milkiewicz P, Oo YH, Heneghan MA, Lohse AW; IAIHG Consortium.

Aliment Pharmacol Ther. 2019 Mar;49(5):528-536. doi: 10.1111/apt.15111. Epub 2019 Jan 22. Review.

PMID:
30671977
17.

Prevention of overuse: A view on upper gastrointestinal endoscopy.

de Jong JJ, Lantinga MA, Drenth JP.

World J Gastroenterol. 2019 Jan 14;25(2):178-189. doi: 10.3748/wjg.v25.i2.178. Review.

18.

Genetics of polycystic liver diseases.

Lee-Law PY, van de Laarschot LFM, Banales JM, Drenth JPH.

Curr Opin Gastroenterol. 2019 Mar;35(2):65-72. doi: 10.1097/MOG.0000000000000514.

PMID:
30652979
19.

Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis.

Pape S, Gevers TJG, Belias M, Mustafajev IF, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, Hartl J, Schramm C, Lohse AW, Taubert R, Jaeckel E, Manns MP, Papp M, Stickel F, Heneghan MA, Drenth JPH.

Clin Gastroenterol Hepatol. 2019 Jan 6. pii: S1542-3565(19)30008-4. doi: 10.1016/j.cgh.2018.12.035. [Epub ahead of print]

PMID:
30625402
20.

Risk factors for incidentally detected and symptomatic angiodysplasias: a case-control study with the general population as reference.

Grooteman KV, Dalloyaux S, van den Bemt MCP, de Graaf J, Verbeek ALM, Jackson CS, van Geenen EJM, Drenth JPH.

Eur J Gastroenterol Hepatol. 2019 Apr;31(4):458-462. doi: 10.1097/MEG.0000000000001335.

PMID:
30562184
21.

Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.

Neijenhuis MK, Wijnands TFM, Kievit W, Ronot M, Gevers TJG, Drenth JPH.

Eur Radiol. 2019 Jun;29(6):3062-3068. doi: 10.1007/s00330-018-5851-y. Epub 2018 Dec 12.

22.

Successful HCV treatment of patients on contraindicated anti-epileptic drugs: Role of drug level monitoring.

van Seyen M, Smolders EJ, van Wijngaarden P, Drenth JPH, Wouthuyzen-Bakker M, de Knegt RJ, Honkoop P, El-Sherif O, Colbers A, Back DJ, Burger DM.

J Hepatol. 2019 Mar;70(3):552-554. doi: 10.1016/j.jhep.2018.10.010. Epub 2018 Nov 23. No abstract available.

PMID:
30473264
23.

Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis.

de Boer YS, Gerussi A, van den Brand FF, Wong GW, Halliday N, Liberal R, Drenth JPH, Thorburn D, Bouma G; Dutch Autoimmune Hepatitis Study Group, Heneghan MA.

Clin Gastroenterol Hepatol. 2018 Nov 22. pii: S1542-3565(18)31271-0. doi: 10.1016/j.cgh.2018.11.028. [Epub ahead of print]

PMID:
30471454
24.

Ciprofloxacin penetration into infected hepatic cysts in autosomal dominant polycystic kidney disease: a case report.

Bernts LHP, Wallenburg E, de Jonge HJM, Schaap B, Kusters R, Overtoom TTC, Brüggemann RJM, Drenth JPH, Lantinga MA.

J Antimicrob Chemother. 2019 Mar 1;74(3):829-830. doi: 10.1093/jac/dky456. No abstract available.

PMID:
30452619
25.

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.

Meijer E, Visser FW, van Aerts RMM, Blijdorp CJ, Casteleijn NF, D'Agnolo HMA, Dekker SEI, Drenth JPH, de Fijter JW, van Gastel MDA, Gevers TJ, Lantinga MA, Losekoot M, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Wetzels JF, Zietse R, Gansevoort RT; DIPAK-1 Investigators.

JAMA. 2018 Nov 20;320(19):2010-2019. doi: 10.1001/jama.2018.15870.

26.

Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.

Hirschfield GM, Chazouillères O, Drenth JP, Thorburn D, Harrison SA, Landis CS, Mayo MJ, Muir AJ, Trotter JF, Leeming DJ, Karsdal MA, Jaros MJ, Ling L, Kim KH, Rossi SJ, Somaratne RM, DePaoli AM, Beuers U.

J Hepatol. 2019 Mar;70(3):483-493. doi: 10.1016/j.jhep.2018.10.035. Epub 2018 Nov 9.

27.

The association between obesity and outcomes in acute pancreatitis: an individual patient data meta-analysis.

Smeets XJNM, Knoester I, Grooteman KV, Singh VK, Banks PA, Papachristou GI, Duarte-Rojo A, Robles-Diaz G, Kievit W, Besselink MGH, Verdonk RC, Van Santvoort HC, Drenth JPH, Belias M, Van Geenen EJM; Dutch Pancreatitis Study Group.

Eur J Gastroenterol Hepatol. 2019 Mar;31(3):316-322. doi: 10.1097/MEG.0000000000001300.

PMID:
30399003
28.

Statistical analysis plan of a randomized controlled trial to compare a restrictive strategy to usual care for the effectiveness of cholecystectomy (SECURE trial).

Wennmacker SZ, van Dijk AH, Drenth JPH, Donkervoort SC, Boerma D, Westert GP, van Laarhoven CJHM, Boermeester MA, Dijkgraaf MGW, de Reuver PR.

Trials. 2018 Nov 3;19(1):604. doi: 10.1186/s13063-018-2989-5.

29.

Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study.

Weersink RA, Taxis K, Drenth JPH, Houben E, Metselaar HJ, Borgsteede SD.

Drug Saf. 2019 Apr;42(4):539-546. doi: 10.1007/s40264-018-0744-1.

30.

The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort.

Munsterman ID, Duijnhouwer AL, Kendall TJ, Bronkhorst CM, Ronot M, van Wettere M, van Dijk APJ, Drenth JPH, Tjwa ETTL; Nijmegen Fontan Initiative .

Eur Heart J. 2019 Apr 1;40(13):1057-1068. doi: 10.1093/eurheartj/ehy620.

PMID:
30346512
31.

Clinical response after laparoscopic fenestration of symptomatic hepatic cysts: a systematic review and meta-analysis.

Bernts LHP, Echternach SG, Kievit W, Rosman C, Drenth JPH.

Surg Endosc. 2019 Mar;33(3):691-704. doi: 10.1007/s00464-018-6490-8. Epub 2018 Oct 17. Review.

32.

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues.

van Aerts RMM, Kolkman M, Kievit W, Gevers TJG, Nevens F, Drenth JPH.

Therap Adv Gastroenterol. 2018 Oct 3;11:1756284818804784. doi: 10.1177/1756284818804784. eCollection 2018.

33.

Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis.

van den Brand FF, van der Veen KS, de Boer YS, van Gerven NM, Lissenberg-Witte BI, Beuers U, van Erpecum KJ, van Buuren HR, den Ouden JW, Brouwer JT, Vrolijk JM, Verdonk RC, van Hoek B, Koek GH, Drenth JPH, Guichelaar MMJ, Mulder CJJ, Bloemena E, van Nieuwkerk CMJ, Bouma G; Dutch Autoimmune Hepatitis Study Group.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):940-947.e2. doi: 10.1016/j.cgh.2018.09.046. Epub 2018 Oct 3.

PMID:
30291909
34.

Low yield for routine laboratory checks in follow-up of coeliac disease.

Burger JPW, van der Laan JJH, Jansen TA, Drenth JPH, Roovers EA, Wessels MMS, Wahab PJ.

J Gastrointestin Liver Dis. 2018 Sep;27(3):233-239. doi: 10.15403/jgld.2014.1121.273.jph.

35.

Severity in polycystic liver disease is associated with aetiology and female gender: Results of the International PLD Registry.

van Aerts RMM, Kievit W, de Jong ME, Ahn C, Bañales JM, Reiterová J, Nevens F, Drenth JPH.

Liver Int. 2019 Mar;39(3):575-582. doi: 10.1111/liv.13965. Epub 2018 Oct 8.

PMID:
30225933
36.

Polyp size of 1 cm is insufficient to discriminate neoplastic and non-neoplastic gallbladder polyps.

Wennmacker SZ, van Dijk AH, Raessens JHJ, van Laarhoven CJHM, Drenth JPH, de Reuver PR, Nagtegaal ID.

Surg Endosc. 2019 May;33(5):1564-1571. doi: 10.1007/s00464-018-6444-1. Epub 2018 Sep 10.

37.

Adverse Events of the Duodenal-Jejunal Bypass Liner: a Systematic Review.

Betzel B, Drenth JPH, Siersema PD.

Obes Surg. 2018 Nov;28(11):3669-3677. doi: 10.1007/s11695-018-3441-3. Review.

PMID:
30121857
38.

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.

van den Brand FF, van Nieuwkerk CMJ, Verwer BJ, de Boer YS, de Boer NKH, Mulder CJJ, Bloemena E, Bakker CM, Vrolijk JM, Drenth JPH, Tan ACITL, Ter Borg F, Ter Borg MJ, van den Hazel SJ, Inderson A, Tushuizen ME, Bouma G.

Aliment Pharmacol Ther. 2018 Oct;48(7):761-767. doi: 10.1111/apt.14939. Epub 2018 Aug 15.

39.

Transabdominal ultrasound and endoscopic ultrasound for diagnosis of gallbladder polyps.

Wennmacker SZ, Lamberts MP, Di Martino M, Drenth JP, Gurusamy KS, van Laarhoven CJ.

Cochrane Database Syst Rev. 2018 Aug 15;8:CD012233. doi: 10.1002/14651858.CD012233.pub2. Review.

PMID:
30109701
40.

[A novel in-hospital meal service improves protein and energy intake].

Dijxhoorn DN, van den Berg MGA, Drenth JPH, Wanten GJA.

Ned Tijdschr Geneeskd. 2018 Jul 13;162. pii: D2484. Dutch.

PMID:
30040302
41.

Colon cleansing efficacy and safety with 1 L NER1006 versus sodium picosulfate with magnesium citrate: a randomized phase 3 trial.

Schreiber S, Baumgart DC, Drenth JPH, Filip RS, Clayton LB, Hylands K, Repici A, Hassan C; DAYB Study Group.

Endoscopy. 2019 Jan;51(1):73-84. doi: 10.1055/a-0639-5070. Epub 2018 Jul 19.

PMID:
30025415
42.

Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts.

Wijnands TF, Schoenemeier B, Potthoff A, Gevers TJ, Groenewoud H, Gebel MJ, Rifai K, Manns MP, Drenth JP.

United European Gastroenterol J. 2018 Jul;6(6):919-925. doi: 10.1177/2050640618764940. Epub 2018 Mar 8.

43.

Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study.

Smits LJT, van Esch AAJ, Derikx LAAP, Boshuizen R, de Jong DJ, Drenth JPH, Hoentjen F.

Inflamm Bowel Dis. 2019 Jan 1;25(1):172-179. doi: 10.1093/ibd/izy227.

PMID:
29947795
44.

The Accuracy of Pancreatic Perfusion Computed Tomography and Angiography in Predicting Necrotizing Pancreatitis: A Systematic Review.

Smeets XJNM, Litjens G, Gijsbers K, Prokop M, Drenth JPH, Hermans J, van Geenen EJM.

Pancreas. 2018 Jul;47(6):667-674. doi: 10.1097/MPA.0000000000001067.

PMID:
29894416
45.

Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease.

Munsterman ID, Kendall TJ, Khelil N, Popa M, Lomme R, Drenth JPH, Tjwa ETTL.

Histopathology. 2018 Oct;73(4):612-621. doi: 10.1111/his.13665. Epub 2018 Jul 13.

PMID:
29856896
46.

The association between portal system vein diameters and outcomes in acute pancreatitis.

Smeets XJNM, Litjens G, da Costa DW, Kievit W, van Santvoort HC, Besselink MGH, Fockens P, Bruno MJ, Kolkman JJ, Drenth JPH, Bollen TL, van Geenen EJM.

Pancreatology. 2018 May 15. pii: S1424-3903(18)30112-1. doi: 10.1016/j.pan.2018.05.007. [Epub ahead of print]

PMID:
29784597
47.

Biochemical Effects on the Liver of 1 Month of Alcohol Abstinence in Moderate Alcohol Consumers.

Munsterman ID, Groefsema MM, Weijers G, Klein WM, Swinkels DW, Drenth JPH, Schellekens AFA, Tjwa ETTL.

Alcohol Alcohol. 2018 Jul 1;53(4):435-438. doi: 10.1093/alcalc/agy031.

PMID:
29726886
48.

Safe use of proton pump inhibitors in patients with cirrhosis.

Weersink RA, Bouma M, Burger DM, Drenth JPH, Harkes-Idzinga SF, Hunfeld NGM, Metselaar HJ, Monster-Simons MH, van Putten SAW, Taxis K, Borgsteede SD.

Br J Clin Pharmacol. 2018 Aug;84(8):1806-1820. doi: 10.1111/bcp.13615. Epub 2018 Jun 7.

49.

NAFLD Phenotype in Patients With V-ATPase Proton Pump Assembly Defects.

Jansen JC, Wolthuis D, Van Scherpenzeel M, Ratziu V, Drenth JPH, Lefeber DJ.

Cell Mol Gastroenterol Hepatol. 2018 Jan 18;5(3):415-417.e1. doi: 10.1016/j.jcmgh.2017.12.011. eCollection 2018 Mar. No abstract available.

50.

Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial.

Smeets XJNM, da Costa DW, Fockens P, Mulder CJJ, Timmer R, Kievit W, Zegers M, Bruno MJ, Besselink MGH, Vleggaar FP, van der Hulst RWM, Poen AC, Heine GDN, Venneman NG, Kolkman JJ, Baak LC, Römkens TEH, van Dijk SM, Hallensleben NDL, van de Vrie W, Seerden TCJ, Tan ACITL, Voorburg AMCJ, Poley JW, Witteman BJ, Bhalla A, Hadithi M, Thijs WJ, Schwartz MP, Vrolijk JM, Verdonk RC, van Delft F, Keulemans Y, van Goor H, Drenth JPH, van Geenen EJM; Dutch Pancreatitis Study Group.

Trials. 2018 Apr 2;19(1):207. doi: 10.1186/s13063-018-2583-x.

Supplemental Content

Loading ...
Support Center